IB
BPMC

Intrust Bank’s Blueprint Medicines BPMC Stock Holding History

Intrust Bank’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,382
Closed -$562K – 404
2025
Q2 		$562K Buy
4,382
+825
+23% +$85.7K 0.05% 226
2025
Q1 		$315K Buy
3,557
+118
+3% +$11.5K 0.03% 314
2024
Q4 		$300K Buy
3,439
+382
+12% +$35K 0.03% 330
2024
Q3 		$283K Buy
3,057
+124
+4% +$12.3K 0.03% 336
2024
Q2 		$316K Buy
2,933
+284
+11% +$28.4K 0.03% 316
2024
Q1 		$251K Sell
2,649
-30
-1% -$2.57K 0.03% 354
2023
Q4 		$247K Buy
+2,679
New +$174K 0.03% 347
2022
Q1 		– Sell
-1,941
Closed -$208K – 386
2021
Q4 		$208K Sell
1,941
-121
-6% -$12.7K 0.03% 384
2021
Q3 		$212K Buy
+2,062
New +$192K 0.03% 365

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Intrust Bank's BPMC Position: Q3 2025 in Review

Intrust Bank sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 4,382 shares — an estimated $562K sold.

Intrust Bank first reported a position in BPMC in Q3 2021 and held it in 9 quarters. The position peaked at $562K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Intrust Bank reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Intrust Bank sold 4,382 Blueprint Medicines shares in Q3 2025, an estimated $562K.
  • Intrust Bank first reported a position in Blueprint Medicines in Q3 2021 and held it in 9 quarters.
  • Intrust Bank's Blueprint Medicines position peaked at $562K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Intrust Bank's 13F filing for Q3 2025, filed 10 Nov 2025.